HL-07609/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1987	1
1988	2
1989	6
1990	2
1991	1
1992	4
1993	3
1994	3
1995	2
1996	2
1997	3
1998	2
1999	4
2000	7
2001	6
2002	5
2003	3
2004	1
2005	4
2006	1
2007	2
2009	2
2024	0

1

ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response.

Lansang MC, Hollenberg NK. Lansang MC, et al. J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2):119-24. doi: 10.3317/jraas.2000.013. J Renin Angiotensin Aldosterone Syst. 2000. PMID: 11967801 Free article. Review. No abstract available.

2

Implications of species difference for clinical investigation: studies on the renin-angiotensin system.

Hollenberg NK. Hollenberg NK. Hypertension. 2000 Jan;35(1 Pt 2):150-4. doi: 10.1161/01.hyp.35.1.150. Hypertension. 2000. PMID: 10642291 Review.

3

Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel?

Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hopkins PN, et al. Curr Opin Lipidol. 1996 Aug;7(4):241-53. doi: 10.1097/00041433-199608000-00011. Curr Opin Lipidol. 1996. PMID: 8883500 Review.

4

Metabolic derangements in nonmodulating hypertension.

Gaboury CL, Hollenberg NK, Hopkins PN, Williams R, Williams GH. Gaboury CL, et al. Am J Hypertens. 1995 Sep;8(9):870-5. doi: 10.1016/0895-7061(95)00160-Q. Am J Hypertens. 1995. PMID: 8541001

5

Natural history of benign solid and cystic thyroid nodules.

Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E. Alexander EK, et al. Ann Intern Med. 2003 Feb 18;138(4):315-8. doi: 10.7326/0003-4819-138-4-200302180-00010. Ann Intern Med. 2003. PMID: 12585829

6

Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension.

Williams GH, Fisher ND, Hunt SC, Jeunemaitre X, Hopkins PN, Hollenberg NK. Williams GH, et al. Kidney Int. 2000 Apr;57(4):1404-7. doi: 10.1046/j.1523-1755.2000.00982.x. Kidney Int. 2000. PMID: 10760074 Free article. Review.

7

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.

Hollenberg NK, Fisher ND, Price DA. Hollenberg NK, et al. Hypertension. 1998 Sep;32(3):387-92. doi: 10.1161/01.hyp.32.3.387. Hypertension. 1998. PMID: 9740600 Review.

8

High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.

Alexander EK, Larsen PR. Alexander EK, et al. J Clin Endocrinol Metab. 2002 Mar;87(3):1073-7. doi: 10.1210/jcem.87.3.8333. J Clin Endocrinol Metab. 2002. PMID: 11889166

9

Regulation of aldosterone secretion in hypertensive blacks.

Fisher ND, Gleason RE, Moore TJ, Williams GH, Hollenberg NK. Fisher ND, et al. Hypertension. 1994 Feb;23(2):179-84. doi: 10.1161/01.hyp.23.2.179. Hypertension. 1994. PMID: 8307626

10

Non-modulation as an intermediate phenotype in essential hypertension.

Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams R, Hunt SC, Hopkins PN, Hollenberg NK. Williams GH, et al. Hypertension. 1992 Dec;20(6):788-96. doi: 10.1161/01.hyp.20.6.788. Hypertension. 1992. PMID: 1452294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year